Interscaffolding Additivity: Binding of P1 Variants of
Bovine Pancreatic Trypsin Inhibitor to Four
Serine Proteases
Daniel Krowarsch1
, Michal Dadlez2
, Olga Buczek1
,
Izabela Krokoszynska1
, Arne O. Smalas3 and Jacek Otlewski1
*
1
Institute of Biochemistry and
Molecular Biology, University
of Wrocl/ aw, Tamka 2
50-137 Wrocl/ aw, Poland
2
Institute of Biochemistry and
Biophysics, Polish Academy of
Sciences, ul. Pawinskiego 5A
02-106 Warszawa, Poland
3
Protein Crystallography
Group, Institute of Chemistry
University of Tromso
N-9037 Tromso, Norway
Different families of protein inhibitors of serine proteases share similar
conformation of the enzyme-binding loop, while their scaffoldings are
completely different. In the enzyme-inhibitor complex, the P1 position of
the loop makes numerous contacts within the S1 pocket and signiÂ®cantly
inÂ¯uences the energy of the interaction. Here, we determine the associï¿¾ation energies (Ga values) for the interaction of coded P1 variants of
bovine pancreatic trypsin inhibitor (BPTI) with bovine b-trypsin (BT),
anionic salmon trypsin (AST), bovine a-chymotrypsin (BCHYM), and
human neutrophil elastase (HNE). The respective Ga ranges are 15, 13,
9, and 8 kcal molÃ¿1 (1 cal Âˆ 4.18 J). Next, through interscaffolding addiï¿¾tivity cycles, we compare our set of Ga values determined for BCHYM
and HNE with similar data sets available in the literature for three other
inhibitor families. The analysis of the cycles shows that 27 to 83 % of
cycles fulÂ®l the criteria of additvity. In one particular case (comparison of
associations of P1 variants of BPTI and OMTKY3 with BCHYM) there is
a structural basis for strongly non-additive behaviour. We argue that the
interscaffolding additvity depends on sequential and conformational
similarities of sites where the mutation(s) are introduced and on the parï¿¾ticular substitution. In the second interscaffolding analysis, we compare
binding of the same P1 mutants to BT and AST. The high correlation
coefÂ®cient shows that both trypsins recognize with comparable strength
the non-cognate side-chains. However, the cognate Arg and Lys sideï¿¾chains are recognized signiÂ®cantly more strongly by AST.
# 1999 Academic Press
Keywords: bovine pancreatic trypsin inhibitor; trypsin; chymotrypsin;
*Corresponding author leukocyte elastase; additivity
Introduction
Serine proteases and their natural canonical
protein inhibitors belong to the most intensively
studied models of protein-protein recognition
(Laskowski & Kato, 1980; Janin & Chothia, 1990;
Jones & Thornton, 1996; Otlewski & Apostoluk,
1997). Protein inhibitors do not form a single
group but can be divided into about 20 different
families (Laskowski, 1986). Global structures of
proteins representing different inhibitor families
are completely different and comprise a-helical
proteins, b-sheet proteins, a/b-proteins and differï¿¾ent folds of small disulÂ®de-rich proteins (Bode &
Huber, 1992). The inhibitor binds to the enzyme
through the exposed and convex binding loop,
which is complementary to the active site of the
enzyme (Figure 1). Binding loops of different
inhibitors adopt rather similar, so-called, canonical
conformation, which is deÂ®ned by the torsion
angles of the P3-P3
0 segment (Pn, Pn
0 follow the
notation introduced by Schechter & Berger, 1967).
The mode of recognition is always very similar
and resembles that of an ideal substrate: the short
antiparallel b-sheet formed between the P3 and P1
E-mail address of the corresponding author:
otlewski@bf.uni.wroc.pl
Abbreviations used: AST, anionic salmon trypsin;
BCHYM, bovine a-chymotrypsin; BPTI, bovine
pancreatic trypsin inhibitor; BT, bovine b-trypsin; HNE,
human neutrophil elastase; OMTKY3, turkey ovomucoid
third domain; SLPI, secretory leukocyte protease
inhibitor; Ka, association constant; rmsd, root-meanï¿¾square deviation.
Article No. jmbi.1999.2757 available online at http://www.idealibrary.com on J. Mol. Biol. (1999) 289, 175Â±186
0022-2836/99/210175Â±12 $30.00/0 # 1999 Academic Pressresidues and the 214-216 (chymotrypsinogen numï¿¾bering system) segment of an enzyme. Other
important features include: short (about 2.7 AÃŠ ) conï¿¾tact between the P1 carbonyl carbon atom and the
catalytic Ser195 Og
, two hydrogen bonds between
the amide group of P1 and the carbonyl group of
Ser214 and the side-chain of Ser195, and two
hydrogen bonds between the carbonyl oxygen
atom of P1 and Gly193/Ser195 amide groups. The
similar system of intermolecular hydrogen bonds,
shape complementarity of interacting areas (Jones
& Thornton, 1996) and the lack of conformational
adjustments during complex formation ensure very
similar recognition of different proteases and
inhibitors.
In a stable enzyme-inhibitor complex, about 10-
12 amino acid residues on an inhibitor side and 20-
25 on an enzyme side are in direct contact, providï¿¾ing an intermolecular buried area of 600-900 AÃŠ
(Janin & Chothia, 1990; Janin, 1995). Free energies
of interactions between residues forming the loop
and the protease are often found to be additive
(Wells, 1990; Laskowski et al., 1989). A large part
of the contacts (up to 50 %) involves the P1 residue,
which is placed in the center of the loop and peneï¿¾trates deeply into the S1 speciÂ®city pocket of the
protease. The principial inhibitory activity is often
dictated by this position (e.g. trypsin inhibitors
have Lys or Arg; chymotrypsin inhibitors have
Tyr, Leu or Met). However, amino acid residues
that precede or follow the P1 residue (e.g. P2 or P3
0
)
and those from a sequentially remote region, called
the secondary contact region, can also inÂ¯uence the
association energy (Laskowski et al., 1989).
Here, we determine the inÂ¯uence of the P1 resiï¿¾due of bovine pancreatic trypsin inhibitor (BPTI)
on its interaction with four serine proteases: bovine
b (BT) and salmon anionic trypsins (AST), bovine
a-chymotrypsin (BCHYM) and human neutrophil
elastase (HNE). BPTI is a small protein (58 amino
acid residues) with three disulÂ®de bonds, wellï¿¾deÂ®ned secondary structure and a hydrophobic
core. Crystal and solution structures of BPTI and
proteins homologous to BPTI as well as their
complexes with different proteases have been
thoroughly characterized by X-ray crystallography
(Deisenhofer & Steigemann, 1975; Wlodawer et al.,
1984, 1987; Hynes et al., 1990; Eigenbrot et al., 1990;
Housset et al., 1991; Arnoux et al., 1995) and NMR
spectroscopy (Wagner et al., 1982; Berndt et al.,
1992; Zweckstetter et al., 1996). The P1 residue of
BPTI is the fully exposed Lys15. The wild-type of
BPTI forms tight complexes with a number of serï¿¾ine proteases (Fritz & Wunderer, 1983), particularly
bovine trypsin (Ka Âˆ 1.6  1013 MÃ¿1 at pH 8.0) and
bovine chymotrypsin (Ka Âˆ 6  107 MÃ¿1 at pH 8.0:
Lazdunski et al., 1974). The BPTI mutant K15V is
known to strongly inhibit pancreatic
(Ka Âˆ 3.3  108 MÃ¿1
) and neutrophil (Ka Âˆ 3.6  108
MÃ¿1
) elastases (Kraunsoe et al., 1996). The proteases
studied here possess very different S1 binding
pockets and are archetypes of trypsin-like, chymoï¿¾trypsin-like and elastase-like enzymes. For the
latter two proteases, the precise data on binding of
different P1 side-chains have recently been deterï¿¾mined for three inhibitors: turkey ovomucoid third
domain (OMTKY3; Lu et al., 1997), eglin c (Lu et al.,
1997) and secretory leukocyte protease inhibitor
(SLPI; Eisenberg et al., 1990). This enables the extenï¿¾sive quantitative analysis of analogous mutations
introduced into the binding loops of different
inhibitors on the binding with a serine enzyme, the
interscaffolding additivity comparison (Qasim et al.,
1997). To the best of our knowledge, there is no
information available on recognition energetics of
different amino acid side-chain in the trypsin S1
pocket, hence, interscaffolding additivity analysis is
impossible. Instead, we compare association enerï¿¾gies for bovine b and salmon anionic trypsins. The
enzymes are about 65 % homologous and show
overall displacement in their main-chain atoms of
about 0.8 AÃŠ (Smalas et al., 1994). According to
the kinetic data, the psychrophilic enzyme
from cold-adapted Â®sh species displays up to
20-fold lower Km toward the cognate P1 Arg subï¿¾strate than mesophilic bovine protease (Smalas et al.,
1994). This encouraged us to study the effect of
non-cognate P1 amino acid substitutions to see
whether the stronger binding is a universal propï¿¾erty of the psychrophilic trypsin. Thus, the compariï¿¾son of association energies of the same inhibitor P1
mutants with two homologous serine proteases
offers another type of interscaffolding analysis.
Results
Binding of P1 BPTI mutants to trypsins
Table 1 presents association constants for all 17
P1 mutants of BPTI and the recombinant wild-type
inhibitor (Met52 ! Leu) determined for each of
four proteases: bovine b-trypsin (BT), anionic
salmon trypsin (AST), bovine chymotrypsin
Figure 1. Superimposition of the main-chain P3 Ã¿ P3
0
segments of the inhibitors' binding loops of BPTI grey
(PDB code 1cbw), OMTKY3 dark grey (PDB code 1cho),
and eglin c light grey (PDB code 1acb) as seen in their
complexes with BCHYM. The Figure was made with the
MolMol software.
176 Interscaffolding Additivity    a (BCHYM), and human neutrophil elastase
(HNE). To facilitate further analysis, especially
additivity comparisons, the Ka values were conï¿¾verted into the respective association free energies
(Ga Âˆ Ã¿ RT ln Ka at 295 K) and shown in
Figure 2. The range of Ka values is particularly
broad for both trypsins: about 109
-fold for BT and,
probably, about 1011-fold for AST. The extremely
high Ka values for P1 Arg and Lys variants with
both trypsins could not be precisely determined at
pH 8.3. Instead, they were determined at pH 5.0,
where the interactions are weaker: the Ka value
for the association of BT with the P1 Lys mutant
is 3  1010 MÃ¿1 and with the Arg mutant
8  1010 MÃ¿1
; respective values for AST are
1.3  1012 MÃ¿1 and 5  1012 MÃ¿1
. Based on the
pH-dependence of Ka for BPTI - BT interaction
(Finkenstadt et al., 1974), the estimated Ka values at
pH 8.3 for Lys and Arg variants interacting with
BT are 1.2  1013 MÃ¿1 and 4.5  1013 MÃ¿1 and for
AST are 7.4  1014 MÃ¿1 and 2.8  1015 MÃ¿1
. The
estimated value for P1 Lys BPTI - BT interaction is
in agreement with Ka Âˆ 1.7  1013 MÃ¿1 determined
at pH 8.0 (Vincent & Lazdunski 1973). The estiï¿¾mated Ka values are shown in Figure 2.
In agreement with the narrow trypsin speciÂ®city,
Lys and Arg mutants of BPTI bind to BT about
105
-fold stronger than BPTI with P1 Tyr, which is
the strongest binding non-cognate residue. For
AST, this factor can even approach 107
. The range
of Ka values for non-cognate substrates is about
104
. Aromatic (Tyr, Phe and Trp), large hydroï¿¾phobic (Met and Leu) and polar (Gln, Asn, Ser and
His) side-chains bind stronger than small (Gly and
Ala), b-branched (Val, Ile and Thr) and acidic (Asp
and Glu) residues.
The determination of Ka values for two trypsins
offers a possibility to compare binding of the same
P1 side-chains to two enzymes of very similar
speciÂ®city. The correlation plot of Ga values for
BT versus AST is a straight line with a slope
s Âˆ 0.98 and a correlation coefÂ®cient r Âˆ 0.97
(Table 2). This shows that both trypsins recognize
non-cognate side-chains with similar energetics
and geometry of interaction. In contrast, measureï¿¾Table 1. The association constants Ka (MÃ¿1
) determined for the interaction of BPTI P1 mutants with four serine proï¿¾teases at pH 8.3, temperature 295 K
BCHYM HNE BT AST
Gly 7.9  104 4.6  105 1.5  104 4.3  104
Ala 2.1  106 4.7  108 2.7  105 2.0  105
Ser 2.7  105 6.9  105 3.7  107 nd
Val 2.3  106 6.2  109 4.1  104 1.1  105
Thr 2.5  106 1.2  108 2.9  105 3.0  105
Asp 1.2  104 1.0  103 6.3  104 1.6  104
Asn 9.2  106 1.3  105 2.2  107 1.4  107
Met 9.8  108 1.3  108 3.9  107 3.3  107
Ile 5.9  105 1.6  109 1.1  105 7.9  104
Leu 1.3  109 5.7  108 5.4  106 1.1  107
Lys 8.8  107 7.8  104 1.7  1013a nd
Glu 1.2  105 3.0  103 2.1  106 7.9  105
Gln 5.2  107 6.9  105 2.3  106 7.0  106
His 7.4  107 3.7  104 6.2  106 8.1  106
Arg 2.5  108 1.4  105 nd nd
Phe 2.5  109 1.1  105 1.2  108 1.4  108
Tyr 7.6  109 1.9  104 1.6  108 1.5  108
Trp 5.6  109 1.1  104 7.6  106 8.0  106
a Ka value from Vincent & Lazdunski (1973).
nd, not determined.
Figure 2. The Ã¿(Ga) values for the association of 18
P1 mutants of BPTI with BCHYM, HNE, BT, and AST at
pH 8.3 and 295 K. The estimated values for Arg and
Lys side-chains based on measurements at pH 5.0 are
marked with a broken line.
Interscaffolding Additivity 177                                                                             ments at pH 5.0 show that the Ka values for cogï¿¾nate P1 Lys and Arg inhibitors are about 100-fold
higher for AST than for BT and these data points
would be clearly off the correlation plot.
It is also possible to form thermodynamic addiï¿¾tivity cycles in which the effect of the same amino
acid substitution (e.g. P1 Thr15 ! Phe) in BPTI is
compared for two trypsins (cycle 1):
where: Ga (Thr15 ! Phe)BT Âˆ Ga (Thr15)BT
Ã¿ Ga (Phe15)BT: the difference in the associatï¿¾ion free energy values between Thr15 and
Phe15 mutants of BPTI interacting with BT;
Ga (Thr15 ! Phe)AST Âˆ Ga (Thr15)AST Ã¿ Ga
(Phe15)AST: the difference in the association free
energy values between Thr15 and Phe15 mutants
of BPTI interacting with AST; Ga
(Thr15 ! Phe)Âˆ Ga (Thr15 ! Phe)AST Ã¿ Ga
(Thr15 ! Phe)BT: the non-additivity in association
energy quantitatively describing the departure of
the cycle from additivity.
For 15 mutants, we analyzed all possible 105
(15  14/2) interscaffolding additivity cycles
(Table 3). The key value of the cycle is Ga,
which informs whether the effect of a substitution
is additive. For the ideal interscaffolding additivity,
Ga should equal zero. Instead, jGaj
ranges from 20 to 1430 cal molÃ¿1
, which suggests
that non-additivity occurs essentially in all conï¿¾sidered cases. However, as discussed by Qasim
et al. (1997), the cycle comprises four independent
Ka, each with an estimated error of 20 %, equivalï¿¾ent to 400 cal/mol as an acceptable additivity
range of jGaj values at the 2s level. Our indiï¿¾vidual association constants were measured with
an estimated error 30 % for strong associations
(Ka > 106 MÃ¿1
) and 50 % for weak interactions;
therefore, an average 40 % error was assumed,
which is equivalent to 200 cal molÃ¿1 error in Ga
and, consequently, 800 cal molÃ¿1 as an acceptable
additivity range of Ga values. In agreement
with the high correlation coefÂ®cient (Table 2), 86 of
105 additivity cycles (82 %) reported in Table 3 ful-
Â®l the additivity criteria. Some of the amino acid
side-chains (Met, Phe, Thr, Trp, Tyr and His)
clearly produce additive effects. The remaining 19
cycles (18 %) are weakly non-additive:
800 < jGaj < 1450 cal molÃ¿1
. Particular nonï¿¾additivity involves P1 Asp (eight of 14 cycles).
Association constants for BCHYM and HNE
Compared with trypsins, the dynamic ranges of
Ka values are signiÂ®cantly narrower for BCHYM,
6.3  105
-fold, and HNE, 2  106
-fold (Table 1 and
Figure 2). The data presented are in agreement
with the general conclusions on BCHYM
(Schellenberger et al., 1991; Lu et al., 1997) and
HNE (Lu et al., 1997) speciÂ®cities reported in the
literature. None of these enzymes shows as clear
speciÂ®city toward any kind of amino acid side
chain(s) as trypsins exhibit towards Arg and Lys.
BCHYM association energies are distributed conï¿¾tinuously. The S1 pocket of BCHYM is shaped to
bind aromatic residues together with Leu and Met.
In the case of HNE, a clear-cut separation into two
groups can be noticed. The P1 amino acid residues
that bind strongly have medium-sized hydroï¿¾phobic side-chains, including all b-branched ones,
and Ala, Leu and Met. Aromatic, charged and
polar residues form the other group of poorly
binding P1 residues. Interestingly, for all four
enzymes studied, particularly weak binding can be
Table 2. The values of r and s calculated for the correlation of Ga values of different protease-inhibitor associations
Enzyme - inhibitor All pointsa - Lys, Arg
x-Axis y-Axis # r s # r s
BCHYM - BPTI BCHYM - OMTKY3 (Lu et al., 1997) 18 0.92 1.09 16 0.99 1.16
BCHYM - eglin c (Qasim et al., 1997) 7 0.98 1.05
BCHYM - SLPI (Eisenberg et al. 1990) 6 0.81 0.81 4 0.97 0.94
BT - BPTI 17 0.51 0.58 16 0.72 0.49
AST - BPTI 15 0.9 0.61
HNE - BPTI 18 Ã¿0.02 Ã¿0.03 16 0.01 0.01
log(kcat
/Km) for oligopeptide substrates
(Schellenberger et al., 1991) 12 0.79 0.42 10 0.92 0.45
HNE - BPTI HNE - OMTKY3 (Lu et al., 1997) 18 0.97 0.99
HNE - eglin c (Qasim et al., 1997) 7 0.96 0.99
HNE - SLPI (Eisenberg et al. 1990) 5 0.92 0.57
BT - BPTI 17 Ã¿0.31 Ã¿0.29 16 Ã¿0.32 Ã¿0.18
AST - BPTI 15 Ã¿0.22 Ã¿0.12
HNE kcat
/Km data (Harper et al., 1984) 6 0.94 1.28
BT - BPTI AST - BPTI 15 0.97 0.98
BT - SLPI (Eisenberg et al. 1990) 4 0.99 0.85
AST - BPTI BCHYM - OMTKY 3 (Lu et al., 1997) 15 0.86 1.51
# denotes the number of points analyzed, reference to literature data is given in parentheses.
a The lack of entries means that the data are not available for Arg and/or Lys residues.
178 Interscaffolding Additivity   observed for acidic side-chains and for Gly, when
the pocket remains empty after complex formation.
It is possible to compare our data with the
association constants determined for OMTKY3 (Lu
et al., 1997), eglin c (Qasim et al., 1997) and SLPI
(Eisenberg et al., 1990). The particularly large data
set comprises 25 P1 mutants (20 coded and Â®ve
non-coded amino acids) of OMTKY3. The data sets
available for eglin c (seven P1 mutants) and SLPI
(six P1 mutants) are more limited. To facilitate comï¿¾parison, our association constants were measured
under identical conditions as for the association of
OMTKY3 (Lu et al., 1997) and eglin c (Qasim et al.,
1997) P1 variants with BCHYM and HNE. Experï¿¾imental conditions for SLPI association constants
measurements were somewhat different (pH 7.5,
37 C; Eisenberg et al., 1990).
Table 2 shows r and s values of the Pearson proï¿¾duct-moment correlation for comparisons of
BCHYM associations with P1 BPTI variants and
other inhibitors mutants. The correlation plot
measured for BPTI and OMTKY3 mutants with
BCHYM are shown in Figure 3. When two (Arg
and Lys) points, clearly well off the straight line,
are removed, the r value changes from 0.92 to 0.99.
Similarly, the Arg and Lys data points are clearly
off the plot in the BPTI versus SLPI correlation anaï¿¾lyzed for the association with BCHYM (data not
shown), and improvement of the correlation was
observed after the elimination of these two data
points (Table 2).
Besides the correlations, we analyzed interscafï¿¾folding additivity in the form of a thermodynamic
cycle where the effect of the same amino acid subï¿¾stitution (e.g. P1 Leu15 ! Ser) in BPTI and another
inhibitor is compared for a single enzyme (Qasim
et al., 1997). An example of the cycle is shown
below for the association of mutants of BPTI and
OMTKY3 containing either Leu or Ser at position
P1 (residue 15 and 18 in BPTI and OMTKY3,
respectively) with BCHYM (cycle 2). The cycle
descripition is analogous to that of cycle 1:
Table 4 presents the interscaffolding additivity
analysis for associations of P1 mutants of BPTI and
OMTKY3 with BCHYM. For 18 P1 amino acids
compared, there are (18  17/2) Âˆ 153 cycles and,
hence, 153 Ga non-additivity energy entries in
Table 4. In agreement with a visual inspection of
the correlation plot, Lys and Arg side-chains are
least additive (with a single exception for
Arg Â„ Lys substitution) with Ga values
approaching Ã¿4.15 kcal mol
Ã¿1 (Table 4). Also some
other residues, particularly large aromatic ones
(Phe, Trp, Tyr and His) tend to exhibit a non-addiï¿¾tive behaviour. In general, 65 cycles (43 %) are
additive in the jGaj < 800 cal molÃ¿1 range
(Table 3). The additivity cycles were also conï¿¾structed and analyzed based on data available for
eglin c and SLPI. The statistics of all interscaffoldï¿¾ing additivity cycles is given in Table 3; r and s
values of different correlation plots are given in
Table 2.
An interscaffolding additivity comparison was
performed for HNE inhibition. As for BCHYM,
Table 3. The statistics of the interscaffolding additivity cycles involving P1 mutants of BPTI, OMTKY3, eglin c, SLPI,
and BT/AST comparison
jGaj
cal molÃ¿1
BCHYM
BPTI/
OMTKY3
HNE
BPTI/
OMTKY3
BCHYM
BPTI/eglin c
HNE
BPTI/eglin c
BCHYM
BPTI/SLPI
HNE
BPTI/SLPI
BT
BPTI/SLPI
BPTI
BT/AST
# % # % # % # % # % # % # % # %
0-800 65 43 84 55 11 73 6 40 4 27 3 30 5 83 86 82
800-1600 42 27 46 30 4 27 4 27 3 20 2 20 1 17 19 18
>1600 46 30 23 15 0 0 5 33 8 53 5 50 0 0 0 0
total 153 100 153 100 15 100 15 100 15 100 10 100 6 100 105 100
# denotes the number of considered cycles.
Figure 3. The correlation plot for binding of BPTI and
OMTKY3 P1 mutants to BCHYM expressed in the form
of respective association free energies.
Interscaffolding Additivity 179 positive correlations are observed between our
data for the association of P1 BPTI mutants and
OMTKY3, eglin c and SLPI P1 mutants (Table 2).
Both sets appear to be well correlated and no
amino acid(s) seemed to be particularly off the corï¿¾relation line (data not shown). Our data are also
well correlated with log (kcat/Km) of Ala-Ala-Xaa
substrates (Harper et al., 1984).
Discussion
Binding properties of S1 pockets
The proteases studied here possess very different
S1 binding pockets and are the archetypes of trypï¿¾sin-like, chymotrypsin-like and elastase-like
enzymes. Since the S1 pockets of BCHYM (Lu et al.,
1997; Schellenberger et al., 1991) and HNE (Lu et al.,
1987; Harper et al., 1984) have been extensively
characterized using large sets of coded amino
acids, their properties will not be analyzed here.
Although a large number of trypsin mutants have
been designed and analyzed (Perona et al., 1995),
little is known about catalytic and binding energies
of non-cognate amino acid side-chains to trypsin.
For trypsin, only limited kinetic data for Suc-Alaï¿¾Ala-Pro-Xaa-AMC substrates (Xaa Âˆ Arg, Lys, Tyr,
Phe, Leu and Trp) have been reported (Graf et al.,
1988). Our data show a large gap between Ga
values for cognate and non-cognate side-chains,
approaching 6.5 to 9 kcal mol
Ã¿1 (Figure 2). There
are two sources of binding energy for the cognate
side-chains: a major one, involving the ion pair forï¿¾mation between Asp189 at the bottom of the S1
pocket and the charge of the P1 side-chain, and an
additional one resulting from the burial of the
hydrophobic part of the P1 side-chain inside the
pocket. Comparison of P1 Lys, Met and Gly associï¿¾ation energies allows the separation of these two
effects. Except for the charged amino group, Lys
and Met side-chains can be considered similar,
since binding of -CH2- and -S- groups in the S1
pockets of several serine proteases was found to be
energetically equivalent (Lu et al., 1997). If we
assume that enzyme-inhibitor interactions outside
the speciÂ®city pocket are equivalent regardless of
the identity of the P1 residue, we can eliminate all
contributions that do not include the P1 side-chain
by subtracting the Ga value for Gly from
the association free energies for Lys and Met resiï¿¾dues: Ga, Lys Ã¿ Ga, Gly Âˆ Ã¿ 12.03 kcal molÃ¿1 and
Ga, Met Ã¿ Ga, Gly Âˆ Ã¿ 4.60 kcal molÃ¿1
. It appears
that binding of the hydrophobic part of the
Lys side-chain (equivalent to Met) provides
Ã¿4.60 kcal molÃ¿1
, while the remaining part
resulting from the ion pair interaction is
extremely strong: Ã¿12.03 kcal molÃ¿1 Â‡ 4.60 kcal
molÃ¿1 Âˆ Ã¿ 7.43 kcal molÃ¿1
.
As might be expected, due to the presence of
Asp189 at the bottom of the trypsin pocket, placing
a negatively charged P1 side-chain in the pocket is
strongly disfavoured. Surprisingly, the effect is
much more severe for Asp than for the longer Glu,
if estimated from the comparison with the binding
of respective isosteric amide groups. For BT,
Ga,Asn Ã¿ Ga,Asp Âˆ Ã¿ 3.42 kcal molÃ¿1 and Ga,Gln
Ã¿ Ga,Glu Âˆ Ã¿ 0.74 kcal molÃ¿1
. We suppose that
the longer and more Â¯exible side-chain of Glu can
adopt a conformation that allows a more favourï¿¾able interaction of its negative charge with water
molecule(s) or main-chain nitrogen atoms forming
the walls of the pocket. Interestingly, Asp is the
least favoured side-chain for all enzymes studied.
Binding of Gly in the pockets of both trypsins (and
also of BCHYM) is similarly strongly disfavoured.
In the case of chymotrypsin there is no
additional factor(s) generating speciÂ®city. The
association energy origins predominantly from the
burying of the P1 side-chain hydrophobic area in
the S1 pocket; hence, there is a gradual dependence
of the association energy on the size of the hydroï¿¾phobic side-chain, complicated further for residues
with branching, polar or charged atoms (Lu et al.,
Table 4. The non-additivity association energy Ga values (cal molÃ¿1
) for the interaction of 18 P1 mutants of BPTI
and OMTKY3 with BCHYM
Asp 80
Val Ã¿90 Ã¿170
Gly 90 10 180
Met 200 130 290 120
Thr Ã¿350 Ã¿430 Ã¿260 Ã¿440 Ã¿560
Ala Ã¿540 Ã¿620 Ã¿450 Ã¿630 Ã¿740 Ã¿190
Leu 430 350 520 340 220 780 970
Gln Ã¿620 Ã¿690 Ã¿530 Ã¿700 Ã¿820 Ã¿270 Ã¿80 Ã¿1050
Ser 440 360 530 350 240 790 980 10 1060
Ile 500 420 590 410 290 850 1040 70 1120 60
Glu Ã¿700 Ã¿780 Ã¿610 Ã¿790 Ã¿910 Ã¿350 Ã¿160 Ã¿1130 Ã¿90 Ã¿1140 Ã¿1200
His Ã¿870 Ã¿940 Ã¿780 Ã¿950 Ã¿1070 Ã¿520 Ã¿330 Ã¿1300 Ã¿250 Ã¿1310 Ã¿1370 Ã¿160
Trp 1230 1150 1320 1140 1030 1580 1770 800 1850 790 730 1930 2100
Phe 1500 1430 1590 1420 1300 1850 2040 1070 2120 1060 1000 2210 2370 270
Tyr 1570 1500 1490 1660 1370 1930 1150 1130 2110 1080 2190 2280 2440 340 70
Lys Ã¿2420 Ã¿2500 Ã¿2330 Ã¿2510 Ã¿2620 Ã¿2070 Ã¿1880 Ã¿2850 Ã¿1800 Ã¿2860 Ã¿2920 Ã¿1720 Ã¿1550 Ã¿3650 Ã¿3920 Ã¿3990
Arg Ã¿2580 Ã¿2660 Ã¿2490 Ã¿2670 Ã¿2780 Ã¿2230 Ã¿2040 Ã¿3010 Ã¿1960 Ã¿3020 Ã¿3080 Ã¿1880 Ã¿1710 Ã¿3810 Ã¿4080 Ã¿4150 Ã¿160
Asn Asp Val Gly Met Thr Ala Leu Gln Ser Ile Glu His Trp Phe Tyr Lys
The values increase from the upper left to the lower right part of the matrix. Calculations were performed as described for cycle
2. The individual entries are for the column ! row mutations.
180 Interscaffolding Additivity1997). Interestingly, if the cognate trypsin Lys/Arg
amino acids are eliminated, the correlation of
BCHYM and AST binding energies is high and
shows r Âˆ 0.9 (for BT r Âˆ 0.72; Figure 4 and
Table 2). This suggests that both enzymes recogï¿¾nize non-cognate substrates using similar binding
interactions within their S1 pockets.
Compared to BCHYM, the S1 pocket of HNE,
although hydrophobic, is signiÂ®cantly smaller and
prefers hydrophobic amino acid side-chains of
moderate size. The dynamic character of the pocket
allows favourable binding of b-branched sideï¿¾chains, which are strongly disfavoured by BT, AST
and BCHYM (Figure 2). Due to the small size of
the pocket, binding of Gly residue is not as
unfavourable as in the case of trypsin and chymoï¿¾trypsin. The size of the pocket is severely restricted
by the side-chains of Val216 and Asp226, these
positions are occupied by glycine both in BCHYM
and in trypsins. Our data correlate well with kcat/
Km values determined for tripeptide substrates
(Table 2). There is virtually no correlation
(r Âˆ Ã¿ 0.32) if the BPTI association data for nonï¿¾cognate side-chains of trypsins are compared with
the HNE - BPTI data (for BT r Âˆ Ã¿ 0.32 and for
AST r Âˆ Ã¿ 0.22) and if HNE/BCHYM correlation is
performed for all side-chains, r Âˆ 0.02 (Table 2).
This shows that, unlike the situation observed for
BCHYM, the size and dynamic character of the
HNE S1 pocket is a clear determinant of its speci-
Â®city.
Additivity
In recent years the applicability of the thermoï¿¾dynamic additivity principle to protein chemistry
has been tested several times, mainly through
double mutant cycle analysis involving a single
protein (Lu et al., 1997; Carter et al., 1984; Dill,
1997; Ackers & Smith, 1985; Wells, 1990; Horovitz
& Fersht, 1990). Qasim et al. (1997) analyzed interï¿¾scaffolding additivity comparisons made between
seven P1 mutants of OMTKY3 and eglin c, which
do not share a common fold (Figure 5), but show
extremely similar conformations of their binding
loops (Figure 1).
Here, interscaffolding additivity comparisons
were analyzed using two different approaches. In
the Â®rst one we checked whether introduction of
the same amino acid substitutions into structurally
and functionally equivalent regions in different
inhibitors will produce the same effect on the
association with a particular protease. We have
chosen the P1 position of BPTI, which is the bestï¿¾known protease inhibitor, but had not been extenï¿¾sively mutated at its P1 site before. Taking into
account the amino acid sequence and main-chain
Figure 4. The correlation plot of association free enerï¿¾gies of BPTI P1 mutants to BCHYM and AST.
Figure 5. Structures of (a) protein inhibitors BPTI, (b) OMTKY3 and (c) eglin c. Ribbon diagram of the crystal strucï¿¾tures of BPTI pdb code (Scheidig et al., 1997), OMTKY3 (PDB code 1HJA), and eglin c (Frigerio et al., 1992) as seen in
their complexes with BCHYM. The P3-P3
0 segment and the P1 side-chain are shown as darker. SLPI structure (Grutter
et al., 1988) could not be included, as the coordinates are not available in PDB yet. The Figure was drawn with
SYBYL software (Tripos).
Interscaffolding Additivity 181rmsd values, the binding loop of BPTI is more disï¿¾similar both from OMTKY3 and eglin c loops than
OMTKY3 loop is from eglin c (Figure 1 and
Table 5) and offers a possibility of structurally
more remote comparison than OMTKY3/eglin c
(Qasim et al., 1997). We determined the association
energies for 17 P1 mutants of BPTI and the recomï¿¾binant wild-type inhibitor (Met52 ! Leu) and
compared them with the data available in the litï¿¾erature for OMTKY3, eglin c and SLPI inhibitors.
The most extensive additivity comparison comï¿¾prises binding of P1 mutants of BPTI and OMTKY3
to BCHYM. We analyzed 153 interscaffolding addiï¿¾tivity cycles (Table 4). About half of the cycles fulÂ®l
our additivity criteria (Table 3). They involve
mainly small side-chains of Asn, Asp, Val, Gly,
Met, Thr and Ala. On the contrary, long or bulky
side-chains of Arg, Lys, Phe, Tyr and Trp belong to
the least additive ones, suggesting different modes
of interaction with the S1 pocket of BCHYM.
Fortunately, in the case of P1 Lys mutants highï¿¾resolution crystal structures are available for
BCHYM complexes with BPTI (Scheidig et al.,
1997) and OMTKY3 (PDB code 1HJA). The comï¿¾parison of both structures reveals the completely
different conformations of the P1 side-chain. In the
OMTKY3 - BCHYM complex, the side-chain of Lys
extends directly into the pocket, as in typical trypï¿¾sin complexes (Figure 6). In the BPTI - BCHYM
complex, the side-chain of Lys15 bends away from
Ser189 and forms two hydrogen bonds with the
main-chain atoms of enzyme Ser217 (2.8 AÃŠ ) and
Pro13(P3) of inhibitor (3.0 AÃŠ ). Moreover, the Arg
side-chain in a BCHYM complex of Alzheimer's
amyloid b-protein precursor (Scheidig et al., 1997),
which is highly homologous to BPTI, shows
exactly the same bending and difference in interï¿¾actions as observed for BPTI complexed with
BCHYM. The average value of the non-additivity
factor is Ã¿2.32 kcal molÃ¿1 for all cycles involving
Lys and Ã¿2.46 kcal molÃ¿1 for cycles involving Arg.
This value is a measure of the above-mentioned
charged hydrogen bonds that are formed by P1 Lys
in the BPTI - BCHYM complex, and is in agreeï¿¾ment with the experimentally determined G
value of charged hydrogen bonds (Fersht, 1987).
The Arg and Lys data points also lead to a clear
non-additivity in the case of BCHYM association
with BPTI and SLPI (average Ga for
Lys Âˆ Ã¿ 1.43 kcal molÃ¿1 and for Arg Âˆ Ã¿ 1.93 kcal
molÃ¿1
), in agreement with the lack of Pro as a
hydrogen-bond donor at P3. This comparison canï¿¾not be extended to eglin c, due to a lack of data for
P1 Arg and Lys residues. A similar analysis of
other strongly non-additive effects is impossible,
due to a lack of respective spatial structures.
The OMTKY3/eglin c interscaffolding additivity
comparison determined for their interaction with
six different proteases gives 69 % additivity at
IGaI < 800 cal mol
Ã¿1 (Qasim et al., 1997). For
BCHYM, 15 of 21 cycles (71 %) were additive.
Interestingly, all non-addtive cycles included P1
Pro. It seems plausible that the larger non-additivï¿¾ity observed here results from different loop
sequences of BPTI: Pro(P3)-Cys(P2)-Lys(P1) and
OMTKY3: Cys(P3)-Thr(P2)-Lys(P1) and larger
difference in the conformations of their loops as
indicated in Table 5. This is clearly seen from rmsd
values operating in torsion angles: while for the
P3-P3
0 segment of OMTKY3/eglin c the rmsd value
is 20 , it is about 56  for BPTI/OMTKY3 and
BPTI/eglin c superimpositions (Table 5). In conï¿¾clusion, we argue that interscaffolding additivity
may depend on the sequential and conformational
similarity of the regions where the mutation(s) is
introduced, and on a particular substitution, e.g.
the presence of Pro at P3, P2 or P1 sites may lead to
the non-additive behaviour.
In the second approach, we analyzed the oppoï¿¾site situation: two different enzymes of very similar
speciÂ®city were tested for their association energy
with P1 variants of the same inhibitor. BT and AST
show about 65 % amino acid sequence homology
and are very similar in the architecture of their S1
speciÂ®city pockets. The mean rmsd value for the
main-chain atoms of nine residues forming the S1
pocket (189 bottom, 190-192 and 214-220 walls) is
0.13 AÃŠ and 0.27 AÃŠ if the side-chains are included
(Smalas et al., 1994). Among the nine residues
forming the pocket, there is one amino acid differï¿¾ence between the two proteases (Ser217 in BT,
Tyr217 in AST). This change does not seem to
affect the afÂ®nity toward substrates, as the sideï¿¾chain of residue 217 points away from the active
site and makes interactions mostly with the solvent
(Smalas et al., 1994). Nevertheless, AST was found
Table 5. The amino acid sequences and the rmsd values of the P3-P3
0 seqments of BPTI, OMTKY3, elgin c and SLPI
inhibitors
A. The amino acid sequences of the P3-P3
0 segments of BPTI, OMTKY3, eglin c and SLPI
P3 P2 P1 P1
0 P2
0 P3
0
BPTI Pro Cys Lys Ala Arg Ile
OMTKY3 Cys Thr Leu Glu Tyr Arg
Eglin c Val Thr Leu Asp Leu Arg
SLPI Gln Cys Leu Met Leu Asn
B. The values of rmsd for P3-P3
0 segment operating in distances (in AÃŠ , the lower left triangle) and in main-chain torsion angles (in deg., the
upper right triangle) as found in the BCHYM-bound state.
OMTKY 3 Eglin c BPTI
OMTKY 3 19.8 57.9 55.7
Eglin c 0.557
BPTI 0.957 1.013
182 Interscaffolding Additivityto hydrolyze amide bonds at cognate P1 Arg up to
40-fold more efÂ®ciently than BT, primarily due to
the 20-fold decrease in Michaelis constant (Outzen
et al., 1996). Our measurements at pH 5 also show
respectively 40 and 60-fold stronger association of
Lys and Arg side-chains to AST. The direct hydroï¿¾gen bond between Nx of P1 Lys and Od2 of Asp189
(Helland et al., 1998), which is not observed in the
BT - BPTI complex (Huber et al., 1974), is a likely
reason for stronger binding of cognate side-chains.
Another, not observed in the BT - BPTI complex,
hydrogen bond P1 N - 214 O should equally stabilï¿¾ize all other P1 BPTI - AST complexes, compared to
BT complexes, but this does not occur. Instead,
there is a very good correlation between AST and
BT for binding of non-cognate P1 mutants (Table 2).
This is, perhaps, not surprising, since the correï¿¾lations for BT/BCHYM and AST/BCHYM are also
good, if cognate Lys and Arg substrates are elimiï¿¾nated (Figure 4 and Table 2).
In summary, the binding properties of BT, AST
and BCHYM pockets are similar for non-cognate
substrates of trypsin. The tune-up of trypsin speci-
Â®city towards cognate substrates is possible
through hydrogen bond(s) from the P1 side-chain
to Asp189. The further increase of binding energy
observed for the interaction of AST with Lys and
Arg may result from the formation of direct hydroï¿¾gen bonds, instead of water-mediated ones present
in the S1 pocket of BT (Helland et al., 1998). The
structural differences between BT, AST and
BCHYM pockets on one hand, and HNE on the
other, are not restricted to one particular substiï¿¾tution within the pocket, but manifest in pocket
size and dynamics, leading to completely changed
speciÂ®city pattern also toward non-cognate amino
acids.
Materials and Methods
Chemicals
Guanidinium chloride (GdmCl), urea, dimethylsulfoxï¿¾ide (DMSO); N,N-dimethylformamide (DMF), methanol
and acetonitrile were from Merck (Germany). TriÂ¯uoroaï¿¾cetic acid (TFA) was from Fluka (Switzerland). Tris,
sodium acetate, DTT, chloramphenicol, ampicillin,
reduced and oxidized glutathione (GSH and GSSG) were
from Sigma (USA).
The basic components of culture media were purï¿¾chased from Merck (Germany). DNA - modifying
enzymes (phage T4 polymerase, phage T4 ligase and
phage T4 polynucleotide kinase) were from Boehringer
Mannheim (Germany). DNA sequencing kit was from
Amersham (UK) and DNA puriÂ®cation kit was from
QIAGEN (USA). IPTG was from Bachem (Switzerland).
Oligonucleotides were chemically synthetized by
Ransom Hill (USA).
Enzymes
Human neutrophil elastase was a generous gift from
Dr W. Watorek. Bovine chymotrypsin was from
Worthington (USA). Bovine b-trypsin was obtained from
a commercial preparation of Worthington trypsin by afÂ®-
nity chromatography on STI-Sepharose, as described
(Otlewski & Zbyryt, 1994).
Substrates
N-Metoxysuc-L-Ala-L-Ala-L-Pro-L-Val-4-nitroanilide
(MeO-Suc-Ala-Ala-Pro-Val-pNA), N-Bz-L-Val-Gly-L-Argï¿¾4-nitroanilide (Bz-Val-Gly-Arg-pNA), N-Tos-Gly-L-Pro-Lï¿¾Arg-4-nitroanilide (Tos-Gly-Pro-Arg-pNA), N-Bz-L-Argï¿¾4-nitroanilide (Bz-Arg-pNA), N-Suc-L-Phe-4-nitroanilide
(Suc-Phe-pNA) were purchased from Sigma (USA);
N-Bz-L-Ile-L-Glu-Gly-L-Arg-4-nitroanilide (Bz-Ile-Gluï¿¾Gly-Arg-pNA) was from Kabi (Sweden); N-Suc-L-Ala-Lï¿¾Ala-L-Pro-L-Phe-4-nitroanilide (Suc-Ala-Ala-Pro-Pheï¿¾pNA), N-Suc-L-Ala-L-Ala-L-Ala-4-nitroanilide (Suc-Alaï¿¾Ala-Ala-pNA), N-Suc-L-Ala-L-Ala-L-Val-4-nitroanilide
(Suc-Ala-Ala-Val-pNA) and N-Suc-Gly-Gly-L-Phe-4-
nitroanilide were from Bachem (Switzerland); and
4-nitrophenyl 40
-guanidinobenzoate (NPGB) was from
Merck (Germany).
All other reagents were of the analytical or HPLC
grade purity.
Expression and purification of BPTI mutants
All P1 mutants of BPTI were expressed as fusion proï¿¾teins in Escherichia coli strain BL21 (DE3) pLysS using the
phage T7 system (Studier et al., 1990), as described
(Staley & Kim, 1994). All mutants used in this study conï¿¾tained additional mutation Met ! Leu at position 52 to
enable cleavage of the fusion protein by CNBr. PuriÂ®-
cation of BPTI mutants was performed as described
Figure 6. P1 Lys side-chains of two inhibitors BPTI (darker) (Scheidig et al., 1997) and OMTKY3 (lighter) (PDB code
1HJA) bound to the S1 pocket of BCHYM. The Figure was made with SYBYL software (Tripos).
Interscaffolding Additivity 183(Krokoszynska et al., 1998). To ensure high purity,
mutant proteins were puriÂ®ed both in the reduced and
the oxidized state on a Vydac C18 semi-preparative
HPLC column. Solvents A (0.1 % TFA) and B (90 %
acetonitrile, 0.1 % TFA) were mixed with a linear gradiï¿¾ent of 10 % to 60 % solvent B (1.5 ml/minute Â¯ow). Oxiï¿¾dation of BPTI variants (10Ã¿4 M protein concentration)
was performed in 20 mM Tris (pH 8.7), 6  10Ã¿4 M
reduced glutathione and 3  10Ã¿4 M oxidized glutaï¿¾thione, 1 mM EDTA, 4 M urea for one hour at 45 C. A
typical yield of oxidative refolding was 30-50 % (7 to
10 mg of pure protein per liter of culture medium). The
P1 Pro and Cys variants could not be produced, as
HPLC chromatograms showed accumulation of many
single and double-disulÂ®de intermediates and no peak
corresponding to natively folded protein.
Mass spectrometry
Electrospray mass spectrometry of all genetic variants
used in this study was performed with a Finnigan MAT
TSQ-700 equipped with ESI source (USA). Species were
assigned according to their molecular masses. Samples
were dissolved in methanol/water (1:1, v/v) containing
1 % acetic acid. Molecular masses of all variants were
within 1.0 atomic mass unit from those expected from
amino acid sequences, as found by electrospray mass
spectrometry.
Standardisation of enzyme, inhibitor and substrate
stock solutions
Bovine b-trypsin and a-chymotrypsin were dissolved
in 1 mM HCl, 20 mM CaCl2 to obtain the stock of about
1  10Ã¿4 M. Salmon anionic trypsin (1  10Ã¿5 M) was
dissolved in 25 mM diethanolamine, 0.14 M NaCl,
pH 5.5; a 6  10Ã¿5 M solution of HNE was prepared in
50 mM acetate buffer (pH 5.0), 0.2 M NaCl. The exact
concentrations of trypsins stock solutions were deterï¿¾mined by NPGB titration (Chase & Shaw 1970). The
standarized trypsin was used to titrate turkey ovomuï¿¾coid inhibitor. Concentrations of chymotrypsin and HNE
were, in turn, determined by titration with turkey ovoï¿¾mucoid.
The P1 BPTI variants were prepared in 1 mM HCl at
10Ã¿2 Ã¿ 10Ã¿4 M. Concentrations of variants that do not
strongly inhibit any of the proteases (Ka < 108 MÃ¿1
) were
determined spectrophotometrically, assuming a molar
absorbance coefÂ®cient of 5720 MÃ¿1
cmÃ¿1 at 275 nm for
BPTI (Kosen et al., 1981). In the case of strong inhibitors
(Ka > 108 MÃ¿1
), concentration was determined by
titration with a standarized solution of trypsin, chymoï¿¾trypsin or HNE. All substrates were dissolved in
dimethyl sulfoxide (DMSO); 4-Nitrophenyl 4-guanidinoï¿¾benzoate hydrochloride (NPGB) was dissolved in 20 %
acetonitrile in DMSO.
Equilibrium association constants
The equilibrium association constants were deterï¿¾mined in 50 mM Tris (pH 8.3 at 22 C), 20 mM CaCl2,
0.01 % (v/v) Triton X-100 (HNE buffer additionally conï¿¾tained 0.5 M NaCl) using a described procedure (Empie
& Laskowski, 1982; Otlewski & Zbyryt, 1994). The
association constants between wild-type BPTI and P1
Arg BPTI and both trypsins were also measured in
50 mM sodium acetate (pH 5.0), 20 mM CaCl2, 0.01 %
Triton X-100. Increasing concentrations of inhibitor were
added to the constant concentration of appropriate proï¿¾tease and after a suitable incubation time the residual
enzyme activity was measured using turn-over substrate
on a HP8452A diode array spectrophotometer (Hewlett
Packard) or on a microplate reader Spectra Max 340
(Molecular Devices). In order to prevent substrateï¿¾induced dissociation of the complex, the substrates were
used at concentrations Â®ve to ten times lower than the
respective Km values. This problem was particularly
serious during the determination of low association conï¿¾stants. In these cases, substrates with a poor kcat/Km
index were chosen. The experimental data were Â®tted to
the equation (Empie & Laskowski, 1982):
Â‰EÂŠ Âˆ 0:5  fÂ‰E0ÂŠ Ã¿ F  Â‰I0ÂŠ Ã¿ KÃ¿1
a
Â‡
ÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂ
Â…Â‰E0 Â‡ F  Â‰I0ÂŠ Â‡ KÃ¿1
a Ã¿ 4  Â‰E0ÂŠ  F  Â‰I0ÂŠg q Â…1Â†
where [E0] and [I0] are total enzyme and inhibitor conï¿¾centrations, respectively; [E] is residual enzyme concenï¿¾tration; F is the enzyme-inhibitor equimolarity factor.
The low Ka values (below 106 MÃ¿1
) were determined
from two parameter Â®ts, Ka and [E0] were variable and F
was Â®xed at the default value (F Âˆ 1).
Acknowledgments
The work was supported by grant 6 P04B 002 10 from
the Polish Committee for ScientiÂ®c Research. J.O. thanks
Professor Michael Laskowski Jr for numerous discusï¿¾sions. We thank Professor P.S. Kim for the plasmid bearï¿¾ing the wild-type BPTI gene, Dr W. Watorek for the
HNE preparation, Wlodek Apostoluk for help with comï¿¾puter graphics, Honorata Czapinska for several Ka deterï¿¾minations and Lilia Joukova and ZoÂ®a Podgorska for
excellent technical assistance.
References
Ackers, G. K. & Smith, F. R. (1985). Effects of siteï¿¾speciÂ®c amino acid modiÂ®cation on protein interï¿¾actions and biological function. Annu. Rev. Biochem.
54, 597-629.
Apostoluk, W. & Otlewski, J. (1998). Conformational
analysis of the protease binding loop in canonical
protein inhibitors of serine proteinases. Proteins:
Struct. Funct. Genet. 32, 459-474.
Arnoux, B., Merigeau, K., Saludjian, P., Norris, F.,
Norris, K., Bjorn, S., Olsen, O., Petersen, L. &
Ducruix, A. (1995). The 1.6 AÃŠ structure of Kunitzï¿¾type domain from the a3 chain of human type VI
collagen. J. Mol. Biol. 246, 609-617.
Berndt, K. D., Guntert, P., Orbons, L. P. & Wuthrich, K.
(1992). Determination of a high quality nuclear
magnetic resonance solution structure of the bovine
pancreatic trypsin inhibitor and comparison with
three crystal structures. J. Mol. Biol. 227, 757-775.
Bode, W. & Huber, R. (1992). Natural protein proteinase
inhibitors and their interaction with proteinases.
Eur. J. Biochem. 204, 433-451.
Carter, P., Winter, G., Wilkinson, A. J. & Fersht, A. R.
(1984). The use of double mutants to detect strucï¿¾tural changes in theactive site of the tyrosyl-tRNA
synthetase. Cell, 38, 835-840.
184 Interscaffolding Additivity           Chase, T. & Shaw, E. (1970). Titration of trypsin, plasï¿¾min and thrombin with p-nitrophenyl p0
-guanidinoï¿¾benzoate. Methods Enzymol. 19, 20-27.
Deisenhofer, J. & Steigemann, W. (1975). Crystalloï¿¾graphic reÂ®nement of structure of bovine pancreatic
trypsin inhibitor at 1.5 AÃŠ resolution. Acta Crystallog.
sect. B, 31, 238-250.
Dill, K. A. (1997). Additivity principles in biochemistry.
J. Biol. Chem. 272, 701-704.
Eigenbrot, C., Randal, M. & Kossiakoff, A. A. (1990).
Structural effects induced by removal of a disulÂ®deï¿¾bridge: the X-ray structure of the C30A/C51A
mutant of basic pancreatic trypsin inhibitor at
1.6 AÃŠ . Protein Eng. 7, 591-598.
Eisenberg, S. P., Hale, K. K., Heimdal, P. & Thompson,
R. C. (1990). Location of the proteinases inhibitory
region of secretory leukocyte proteases inhibitor.
J. Biol. Chem. 265, 7976-7981.
Empie, M. & Laskowski, M., Jr (1982). Thermodynamics
and kinetics of single residue replacements in avian
ovomucoid third domains: effect of inhibitor interï¿¾actions with serine proteinases. Biochemistry, 21,
2274-2284.
Fersht, A. R. (1987). The hydrogen bond in molecular
recognition. Trends Biochem. Sci. 12, 301-304.
Finkenstadt, W. R., Hamid, M. A., Mattis, J. A., Schrode,
J., Sealock, R. W. & Laskowski, M. (1974). Kinetics
and thermodynamics of the interaction of proteinï¿¾ases with protein inhibitors. In Bayer Symposium V
(Fritz, H., Tschesche, H. & Greene, L. J., eds), pp.
389-411, Springer, Berlin.
Frigerio, F., Coda, A., Pugliese, L., Lionetti, C.,
Menegatti, E., Amiconi, G., Schnebli, H. P., Ascenzi,
P. & Bolognesi, M. (1992). Crystal and molecular
structure of the bovine alpha-chymotrypsin-eglin c
complex at 2.0 AÃŠ resolution. J. Mol. Biol. 225, 107-
123.
Fritz, H. & Wunderer, G. (1983). Biochemistry and
applications of aprotinin, the kallikrein inhibitor
from bovine organs. Arzneim.-Forsch./Drug Res. 33,
479-494.
Graf, L., Jancso, A., Szilagyi, L., Hegyi, G., Pinter, K.,
Naray-Szabo, G., Hepp, J., Medzihradszky, K. &
Rutter, W. J. (1988). Electrostatic complementarity
within the substrate-binding pocket of trypsin. Proc.
Natl Acad. Sci. USA, 85, 4961-4965.
Grutter, M. G., Fendrich, G., Huber, R. & Bode, W.
(1988). The 2.5 AÃŠ X-ray crystal structure of the acidï¿¾stable proteinase inhibitor from human mucous
secretions analysed in its complex with bovine
a-chymotrypsin. EMBO J. 7, 345-351.
Harper, J. W., Cook, R. R., Roberts, C. J., McLaughlin,
B. J. & Powers, J. C. (1984). Active site mapping of
the serine proteases human leukocyte elastase, cathï¿¾epsin G, porcine pancreatic elastase, rat mast cell
proteases I and II. Bovine chymotrypsin A alpha,
and Staphylococcus aureus protease V-8 using triï¿¾peptide thiobenzyl ester substrates. Biochemistry, 23,
2995-3002.
Helland, R., Leiros, I., Berglund, G. I., Willassen, N. P.
& SmalaÃŠ s, A. O. (1998). The crystal structure of
anionic salmon trypsin in complex with bovine panï¿¾creatic trypsin inhibitor. Eur. J. Biochem. 256, 317-
324.
Horovitz, A. & Fersht, A. R. (1990). Strategy for analysï¿¾ing the co-operativity of intramolecular interactions
in peptides and proteins. J. Mol. Biol. 214, 613-617.
Housset, D., Kim, K.-S., Fuchs, J., Woodward, C. &
Wlodawer, A. (1991). Crystal structure of a Y35G
mutant of bovine pancreatic trypsin inhibitor. J. Mol.
Biol. 220, 757-770.
Huber, R., Kukla, D., Bode, W., Schwager, P., Bartels,
K., Deisenhofer, J. & Steigemenn, W. (1974). Strucï¿¾ture of the complex formed by bovine trypsin and
bovine pancreatic trypsin inhibitor. II. Crystalloï¿¾graphic reÂ®nement at 1.9 AÃŠ resolution. J. Mol. Biol.
89, 73-101.
Hynes, T. R., Randal, M., Kennedy, L. A., Eigenbrot, C.
& Kossiakoff, A. A. (1990). X-Ray crystal structure
of the inhibitor domain of Alzheimer's amyloid bï¿¾protein precursor. Biochemistry, 29, 10018-10022.
Janin, J. (1995). Elusive afÂ®nities. Proteins: Struct. Funct.
Genet. 21, 30-39.
Janin, J. & Chothia, C. (1990). The structure of proteinï¿¾protein recognition sites. J. Biol. Chem. 265, 16027-
16030.
Jones, S. & Thornton, J. M. (1996). Principles of proteinï¿¾protein interactions. Proc. Natl Acad. Sci. USA, 93,
13-20.
Kosen, P. A., Creighton, T. E. & Blout, E. R. (1981). Cirï¿¾cular dichroism spectroscopy of bovine pancreatic
trypsin inhibitor and Â®ve altered confrormational
states. Relationship of conformation and the refoldï¿¾ing pathway of the trypsin inhibitor. Biochemistry,
20, 5744-5754.
Kraunsoe, J. A., Claridge, T. D. & Lowe, G. (1996). Inhiï¿¾bition of human leukocyte and porcine pancreatic
elastase by homologues of bovine pancreatic trypsin
inhibitor. Biochemistry, 35, 9090-9096.
Krokoszynska, I., Dadlez, M. & Otlewski, J. (1998).
Structure of single-disulÂ®de variants of bovine panï¿¾creatic trypsin inhibitor (BPTI). as probed by their
binding to bovine b-trypsin. J. Mol. Biol. 275, 503-
513.
Laskowski, M., Jr (1986). Protein inhibitors of serine proï¿¾teinases - mechanism and classiÂ®cation. In Nutriï¿¾tional and Toxicological SigniÂ®cance of Enzyme
Inhibitors (Friedman, M., ed.), pp. 1-17, Plenum,
New York.
Laskowski, M., Jr & Kato, I. (1980). Protein inhibitors of
proteinases. Annu. Rev. Biochem. 49, 593-626.
Laskowski, M., Jr, Park, S. J., Tashiro, M. & Wynn, R.
(1989). Design of highly speciÂ®c inhibitors of serine
proteinases. In UCLA Symposia on Molecular and Celï¿¾lular Biology, New Series, 80 (Hutchens, T. W., ed.),
pp. 149-168, Alan R. Liss, New York.
Lazdunski, M., Vincent, J.-P., Schweitz, H., Peronï¿¾Renner, M. & Pudles, J. (1974). The mechanism of
association of trypsin (or chymotrypsin) with the
pancreatic trypsin inhibitors (Kunitz and Kazal).
Kinetics and thermodynamics of the interaction. In
Bayer Symposium V (Fritz, H., Tschesche, H. &
Greene, L. J., eds), pp. 420-431, Springer Verlag,
Berlin.
Lu, W., Apostol, I., Qasim, M. A., Warne, N., Wynn, R.,
Zhang, W. L., Anderson, S., Chiang, Y. W.,
Rothberg, I., Ryan, K. & Laskowski, M., Jr. (1997).
Binding of amino acid side chains to S1 cavities of
serine proteinases. J. Mol. Biol. 266, 441-461.
Otlewski, J. & Apostoluk, W. (1997). Structural and
energetic aspects of protein-protein recognition.
Acta Biochim. Polon., 44, 367-388.
Otlewski, J. & Zbyryt, T. (1994). Single peptide bond
hydrolysis/resynthesis in squash inhibitors of serine
proteinases. I. Kinetics and thermodynamics of the
interaction between squash inhibitors and bovine bï¿¾trypsin. Biochemistry, 33, 200-207.
Interscaffolding Additivity 185Outzen, H., Berglund, G. I., Smalas, A. O. & Willassen,
N. P. (1996). Temperature and pH sensitivity of
trypsins from Atlantic salmon (Salmo salar) in comï¿¾parison with bovine and porcine trypsin. Comp. Bioï¿¾chem. Biophys. 115, 33-45.
Perona, J. J., Hedstrom, L., Rutter, W. J. & Fletterick, R. J.
(1995). Structural origins of substrate discrimination
in trypsin and chymotrypsin. Biochemistry, 34, 1489-
1499.
Qasim, M. A., Ganz, P. J., Saunders, C. W., Bateman,
K. S., James, M. N. G. & Laskowski, M., Jr (1997).
Interscaffolding additivity. Association of P1 varï¿¾iants of eglin c and of turkey ovomucoid third
domain with serine proteinases. Biochemistry, 36,
1598-1607.
Schechter, P. & Berger, A. (1967). On the size of the
active site in proteases. I. Papain. Biochem. Biophys.
Res. Commun. 27, 157-162.
Scheidig, A. J., Hynes, T. R., Pelletier, L. A., Wells, J. A.
& Kossiakoff, A. A. (1997). Crystal structures of
bovine chymotrypsin and trypsin complexed to the
inhibitor domain of Alzheimer's amyloid beta-proï¿¾tein precursor (APPI) and basic pancreatic trypsin
inhibitor (BPTI): engineering of inhibitors with
altered speciÂ®cities. Protein. Sci. 6, 1806-1824.
Schellenberger, V., Braune, K., Hofmann, H. J. &
Jakubke, H. D. (1991). The speciÂ®city of chymotrypï¿¾sin. A statistical analysis of hydrolysis data. Eur. J.
Biochem. 199, 623-636.
Smalas, A. O., Heimstad, E. S., Hordvik, A., Willassen,
N. P. & Male, R. (1994). Cold adaption of enzymes:
structural comparison between salmon and bovine
trypsins. Proteins: Struct. Funct. Genet. 20, 149-166.
Staley, J. P. & Kim, P. S. (1994). Formation of a nativeï¿¾like subdomain in a partially folded intermediate of
bovine pancreatic trypsin inhibitor. Protein Sci. 3,
1822-1832.
Studier, F. W., Rosenberg, A. H., Dunn, J. J. &
Dubendorff, J. W. (1990). Use of T7 polymerase to
direct expression of cloned genes. Methods Enzymol.
185, 60-89.
Vincent, J.-P. & Lazdunski, M. (1973). The interaction
between alpha-chymotrypsin and pancreatic trypsin
inhibitor (Kunitz inhibitor). Kinetic and thermodynï¿¾amic properties. Eur. J. Biochem. 38, 365-372.
Wagner, G., Braun, W., Havel, T. F., Schaumann, T., Go,
N. & Wuthrich, K. (1982). Protein structures in solï¿¾ution by nuclear magnetic resonance and distance
geometry. The polypeptide of the basic pancreatic
trypsin inhibitor determined using two different
algorithms, DISGEO and DISMAN. J. Mol. Biol. 196,
611-639.
Wells, J. A. (1990). Additivity of mutational effects in
proteins. Biochemistry, 29, 8509-8517.
Wlodawer, A., Walter, J., Huber, R. & Sjolin, L. (1984).
Structure of bovine pancreatic trypsin inhibitor.
Results of joint neutron and X-ray reÂ®nement of
crystal form II. J. Mol. Biol. 180, 301-329.
Wlodawer, A., Nachman, J., Gilliand, G. L., Gallagher,
W. & Woodward, C. (1987). Structure of form III
crystals of bovine pancreatic trypsin inhibitor. J. Mol.
Biol. 198, 469-480.
Zweckstetter, M., Czisch, M., Mayer, U., Chu, M.-L.,
Zinth, W., Timpl, R. & Holak, T. A. (1996). Strucï¿¾ture and multiple conformations of the Kunitz-type
domain from human type VI collagen a3(VI) chain
in solution. Structure, 4, 195-209.
Edited by R. Huber
(Received 4 January 1999; received in revised form 26 March 1999; accepted 26 March 1999)
186 Interscaffolding Additivity